ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Fabrication of Site-Specific 3D Structures via Macroscopic Supramolecular Assembly for Spatially Controlled Alignment of Multiple Cells.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fabrication of Site-Specific 3D Structures via Macroscopic Supramolecular Assembly for Spatially Controlled Alignment of Multiple Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The self-assembly of micrometer-to-millimeter components, referred to as "macroscopic supramolecular assembly (MSA)," offers an efficient approach for constructing cell-scale 3D bioactive structures with flexible modular designs. Compared with available 3D bio-printing or conventional modular assembly of cell-material units, MSA is advantageous in decoupling material preparation and cell loading processes by directing cell adhesion after the preparation of 3D structures, which minimizes the trade-off between cell viability and material selection. But the challenge lies in efficient self-sorting of different cells and spatially controlled cell distribution. Hence, MSA is combined with the surface chemistry of orthogonally specific peptides to different cells and magnetic manipulation, and fabricated 3D bioactive structures that direct cell sorting. Microscale polydimethylsiloxane (PDMS) components are modified with 1) Arg-Glu-Asp-Val and Val-Ala-Pro-Gly peptides affinitive to endothelial cells (ECs) and smooth muscle cells (SMCs), respectively, and 2) host/guest molecules as "supramolecular glues" for precise structuring and interfacial bonding. Self-sorting and spatially controlled adhesion of ECs and SMCs is achieved to mimic layered vascular structures. This "Lego-like" strategy is free of compromising cell viability with structure design, thus contributing to spatially intricate and bioactive 3D architectures, and promoting the development of MSA from fundamental advances to applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.